BioCentury
ARTICLE | Clinical News

Immunomedics preclinical data

December 16, 2002 8:00 AM UTC

hA20 bound CD20 on human NHL cells grown in cell culture or in mice, and was similar to Rituxan in controlling the growth in a mouse model of NHL, extending survival 400 to 600% compared to control. ...